Tmunity Therapeutics
Pioneering the future of immunotherapy through innovative T cell engineering to tackle a diverse array of diseases.
12 employees · est. 2015
Tmunity Therapeutics is the older company (2016 vs 2015); bit.bio is the larger of the two.
Side-by-Side Comparison
| Metric | bit.bio | Tmunity Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2015 older |
| Headquarters | ||
| Headquarters | Cambridge, United Kingdom | Not tracked yet |
| Employees | ||
| Employees | 164 larger | 12 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series C | Acquired |
| Total Funding | ||
| Total Funding | $224.85M | $220.00M |
| Funding Rounds | ||
| Funding Rounds | 8 | 6 |
| Services | ||
| Services | CRISPR Screening, Custom ioCells Development, Custom ioDisease Model Cells, Cell Programming Platform, Therapeutics Development | Not tracked yet |
| Target Customers | ||
| Target Customers | Biotech Companies, Pharmaceutical Companies, Academic Researchers, Drug Development Labs | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Human Synthetic Biology, Precision Cell Programming, Stem Cell Biology, Cell Therapy, Cellular Reprogramming, Pharmaceutical Drug Discovery, Human IPSCs, Mathematical Modeling, Cell Type Development, High Throughput Screening, Research And Drug Discovery, Cell And Tissue Therapies, Biological Consistency, Opti-ox Technology | Immunotherapy, T Cell Engineering, T Cell Receptor (TCR), Regulatory T Cells (Treg), Universal Engineered T Cells, Genetically Engineered T Cells, Oncology, Infectious Diseases, Autoimmune Disorders, Clinical Trials, Cell And Gene Therapy, Peripheral Blood T Cells, Cord Blood T Cells, Tumor Derived T Cells, Multi-center Clinical Studies |
| Website | ||
| Website | bit.bio | tmunity.com |
About bit.bio
bit.bio, headquartered in the United Kingdom and founded in 2016, is an innovative player in the Biotechnology and Health Care sectors, distinguished by their slogan, "The Cell Coding Company." Their mission is to code cells for novel cures using a proprietary cell programming technology called opti...
About Tmunity Therapeutics
Tmunity Therapeutics, founded in 2015, is at the forefront of biotech innovation, striving to reshape the landscape of immunotherapy through its pioneering work in T cell engineering. The company emphasizes T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered...
We will tell you when either one moves
BounceWatch watches bit.bio and Tmunity Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at bit.bio and Tmunity Therapeutics — by email.
Frequently Asked Questions
Compare bit.bio with someone else
Start typing a company name or domain.
Related Comparisons
Compiled from the BounceWatch company index. We last looked at bit.bio on 15 Jun 2026, and Tmunity Therapeutics on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.